Cost effectiveness of routine histology for haemorrhoidectomy specimens

Not Applicable

Completed

• Conditions: Haemorrhoids; Anal cancer; Cancer - Bowel - Anal; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12621001124820
• Lead Sponsor: Henry Watter

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-07-09
• Study Start: 2021-08-23
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 119

Inclusion Criteria

Patients who underwent haemorrhoidectomies at Hervey Bay Hospital between 1st March 2012 and 18th May 2020

Exclusion Criteria

Those who had preoperative or intraoperative suspicion of a pathology other than haemorrhoids

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cost of histological analysis per case of incidental anal cancer. This will be done by accessing medical records of all patients receiving haemorrhoidectomy to determine histological diagnosis, and comparing to the cost of histological analysis as stated by the pathology provider.[At time of haemorrhoidectomy]

Secondary Outcome Measures

Name	Time	Method
Proportion of haemorrhoidectomy specimens sent for histology. This will be done by accessing medical records of all patients receiving haemorrhoidectomy.[At time of haemorrhoidectomy]